AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: Significant differences in survival with standard chemotherapy

Journal of Clinical Oncology

Volumn 23, Issue 19, 2005, Pages 4430-4438

  Lim, Soon Thye ^a   Karim, Roksana ^a   Nathwani, Bharat N ^a   Tulpule, Anil ^a   Espina, Byron ^a   Levine, Alexandra M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; VINCRISTINE; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT; CHOP PROTOCOL; DEXAMETHASONE; FOLINIC ACID; M BACOD PROTOCOL; M-BACOD PROTOCOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; B CELL LYMPHOMA; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLEOMYCIN; BURKITT LYMPHOMA; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FEMALE; HUMANS; LEUCOVORIN; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 22344450861     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.11.973     Document Type: Article

References (47)

1. Butler RD, Hainsworth JD: Optimal therapy for small noncleaved cell lymphoma. Cancer Treat Res 66:65-79, 1993
2. McMaster ML, Greer JP, Greco FA, et al: Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J Clin Oncol 9:941-946, 1991
3. Smeland S, Blystad AK, Kvaloy SO, et al: Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: A 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens. Ann Oncol 15:1072-1078, 2004
4. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage-A report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 13:359-372, 1995
5. Magrath I, Adde M, Shad A, et al: Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14:925-934, 1996
6. Soussain C, Patte C, Ostronoff M, et al: Small noncleaved cell lymphoma and leukemia in adults: A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85:664-674, 1995
7. Patte C, Philip T, Rodary C, et al: High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123-132, 1991
8. Thomas DA, Cortes J, O'Brien S, et al: Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol 17:2461-2470, 1999
9. Blum KA, Lozanski G, Byrd JC: Adult Burkitt leukemia and lymphoma. Blood 104:3009-3020, 2004
10. Levine AM, Wernz JC, Kaplan L, et al: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma: A prospective multi-institutional trial. JAMA 266:84-88, 1991
11. Kaplan LD, Straus DJ, Testa MA, et al: Low-dose compared with standard-dose M-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection: National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 336:1641-1648, 1997
12. Kaplan LD, Abrams DI, Feigal E, et al: AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261:719-724, 1989
13. Lowenthal DA, Straus DJ, Campbell SW, et al: AIDS-related lymphoid neoplasia: The Memorial Hospital experience. Cancer 61:2325-2337, 1988
14. Knowles DM, Chamulak GA, Subar M, et al: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 108:744-753, 1988
15. Straus DJ, Juang J, Testa MA, et al: Prognostic factors in the treatment of HIV associated non-Hodgkin's lymphoma: Analysis of AIDS Clinical Trials Group protocol 142-Low dose versus standard dose m-BACOD plus GM-CSF. J Clin Oncol 16:3601-3606, 1998
16. Vaccher E, Tirelli U, Spina M, et al: Age and serum LDH level are independent prognostic factors in HIV related non-Hodgkin's lymphoma: A single institution study of 96 patients. J Clin Oncol 14:2217-2223, 1996
17. Palella FJ Jr, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N Engl J Med 338:853-860, 1998
18. Antinori A, Cingolani A, Alba L, et al: Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 15:1483-1491, 2001
19. Hoffmann C, Wolf E, Fatkenheuer G, et al: Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS 17:1521-1529, 2003
20. Tam HK, Zhang ZF, Jacobson LP, et al: Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 98:916-922, 2002
21. Vaccher E, Spina M, Talamini R, et al: Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy. Clin Infect Dis 37:1556-1564, 2003
22. Levine AM, Tulpule A, Espina B, et al: Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: Results of therapy and correlates of response. J Clin Oncol 22:2662-2670, 2004
23. Ratner L, Lee J, Tang S, et al: Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19:2171-2178, 2001
24. Costello RT, Zerazhi H, Charbonnier A, et al: Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus. Cancer 100:667-676, 2004
25. Re A, Cattaneo C, Michieli M, et al: High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 21:4423-4427, 2003
26. Krishnan A, Molina A, Zaia J, Smith D, et al: Durable remissions with autologous stem cell transplantation for high risk HIV-associated lymphomas. Blood 105:874-878, 2005
27. Wang ES, Straus DJ, Teruya-Feldstein J, et al: Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer 98:1196-1205, 2003
28. Cortes J, Thomas D, Rios A, et al: Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 94:1492-1499, 2002
29. Lukes RJ, Collins RD: Immunologic characterization of human malignant lymphomas Cancer 34:1488-1503, 1974 (suppl 4)
30. Lukes RJ, Parker JW, Taylor CR, et al: Immunologic approach to non-Hodgkin lymphomas and related leukemias: Analysis of the results of multiparameter studies of 425 cases. Semin Hematol 15:322-351, 1978
31. Cox DR, Oakes D: Analysis of Survival Data. London, United Kingdom, Chapman and Hall, Methuen, 1984
32. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY, John Wiley & Sons Inc, 1980
33. Tarone RE, Ware J: On distribution-free tests for equality of survival distributions. Biometrika 64:156-160, 1977
34. Gabarre J, Raphael M, Lepage E, et al: Human immunodeficiency virus-related lymphoma: Relation between clinical features and histologic subtypes. Am J Med 111:704-711, 2001
35. Levine AM, Sullivan-Halley J, Pike MC, et al: Human immunodeficiency virus-related lymphoma: Prognostic factors predictive of survival. Cancer 68:2466-2472, 1991
36. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
37. International Collaboration on HIV and Cancer: Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823-1830, 2000
38. Besson C, Goubar A, Gabarre J, et al: Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339-2344, 2001
39. Kirk O, Pedersen C, Cozzi-Lepri A, et al: Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98:3406-3412, 2001
40. Wolf T, Brodt HR, Fichtischerer S, et al: Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 46:207-215, 2005
41. Levine AM, Seneviratne L, Espina BM, et al: Evolving characteristics of AIDS-related lymphoma. Blood 96:4084-4090, 2000
42. Straus DJ: Treatment of Burkitt's lymphoma in HIV-positive patients. Biomed Pharmacother 50:447-450, 1996
43. Pluda JM, Venzon DJ, Tosato G, et al: Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 11:1099-1107, 1993
44. Levine AM: Acquired immunodeficiency syndrome-related lymphoma: Clinical aspects. Semin Oncol 27:442-453, 2000
45. Spina M, Tirelli U, Zagonel V, et al: Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: A single-institution clinicopathologic study of 75 patients. Cancer 82:766-774, 1998
46. Vaccher E, Tirelli U: Burkitt's like lymphoma in patients with and without HIV infection. A report of 33 patients from north-east Italy. Acta Oncol 33:507-511, 1994
47. NCI Non-Hodgkin's Lymphoma Classification Project Writing Committee: Classification of non-Hodgkin's lymphomas: Reproducibility of major classification systems. Cancer 55:91-95, 1985